Cargando…

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection

BACKGROUND: Chronic antibody-mediated rejection (CABMR) is an important cause of late graft loss. De novo donor-specific antibody (dnDSA) is an important prognostic factor for long-term allograft outcomes. However, the prognosis of CABMR based on the presence of dnDSA is uncertain. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Woo Yeong, Kim, Yaerim, Paek, Jin Hyuk, Jin, Kyubok, Han, Seungyeup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Transplantation 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235340/ https://www.ncbi.nlm.nih.gov/pubmed/35769616 http://dx.doi.org/10.4285/kjt.20.0052

Ejemplares similares

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2021)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
por: Park, Hanil, et al.
Publicado: (2022)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report
por: Kwon, Ohyun, et al.
Publicado: (2022)

Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population
por: Kwak, Jin Ho, et al.
Publicado: (2022)

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2018)

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
por: Chowdhry, Mohit, et al.
Publicado: (2019)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study
por: Lee, Jong Hoon, et al.
Publicado: (2018)

Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality
por: Paek, Jin Hyuk, et al.
Publicado: (2020)

Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies
por: Zhu, Lan, et al.
Publicado: (2021)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Incidence and Clinical Significance of De Novo Donor Specific Antibodies after Kidney Transplantation
por: Lionaki, Sophia, et al.
Publicado: (2013)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Impact of acute kidney injury in deceased donors with high Kidney Donor Profile Index on posttransplant clinical outcomes: a multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2021)

Impact of Kidney Donor Profile Index Scores on Post-Transplant Clinical Outcomes Between Elderly and Young Recipients, A Multicenter Cohort Study
por: Park, Woo Yeong, et al.
Publicado: (2020)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
por: Ban, Tae Hyun, et al.
Publicado: (2019)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

Clinical significance of CD161(+)CD4(+) T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients
por: Kim, Kyoung Woon, et al.
Publicado: (2018)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients
por: Yazawa, Masahiko, et al.
Publicado: (2019)

Antibody-Mediated Rejection in Kidney Transplantation: A Retrospective Study on the Impact of Donor-Specific Antibodies and on the Timing of Diagnosis
por: Reis Pereira, Pedro, et al.
Publicado: (2022)

A Pedigree with c.179 Cytosine to Threonine Missense Mutation of SLC12A3 Gene Presenting Gitelman's Syndrome
por: Kim, Yaerim, et al.
Publicado: (2016)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2019)

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients
por: Mertens, Inge, et al.
Publicado: (2020)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022)

Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection
por: Wang, Junpeng, et al.
Publicado: (2023)

Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report
por: Yeo, Sang Mok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bidvo3v84d7abkh2q7atj8fjnb